Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

September 29, 2017News

Oncology Innovation Has Produced Major Drop in Pediatric Cancer Deaths

BIOtech Now Jim Greenwood One of the toughest parts of working in the biotechnology industry is the likelihood that you will eventually […]

September 28, 2017News

ICYMI: Citizens Against Government Waste Speaks Out Against Waste in 340B Drug Discount Program

BIOtech Now Daniel Seaton Writing this week for The Hill, Elizabeth Wright of Citizens Against Government Waste highlights an egregious example of […]

September 22, 2017News

Insurer Shifting Blame for Rising Premiums

BIOtech Now Brian Newell According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem is proposing a […]

September 21, 2017News

New Infographic: A Response to “A Better Deal” on Drug Pricing

BIOtech Now Brian Newell The United States is the global leader in biomedical innovation, discovering more new cures than the rest of […]

September 12, 2017News

JAMA Study Misses the Mark on Cancer R&D Costs & Profitability

BIOtech Now Jim Greenwood Yesterday, JAMA Internal Medicine published a new paper purporting to estimate the R&D expense associated with developing and […]

September 8, 2017News

Online Learning for Busy Researchers 12

BioTechniques News Summer is over, and now it’s time to buckle down. Why not expand your horizons with a free or low-cost […]

September 8, 2017News

Online Learning for Busy Researchers 11

BioTechniques News Summer is over, and now it’s time to buckle down. Why not expand your horizons with a free or low-cost […]

September 8, 2017News

Online Learning for Busy Researchers 10

BioTechniques News Summer is over, and now it’s time to buckle down. Why not expand your horizons with a free or low-cost […]

September 7, 2017News

Online Learning for Busy Researchers

BioTechniques News Summer is over, and now it’s time to buckle down. Why not expand your horizons with a free or low-cost […]

September 7, 2017News

Expanded Access – It Continues to Make Headlines

BIOtech Now BIOtechNOW Editor The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn Right to Try […]

September 7, 2017News

Zika Virus, Immunosuppression, and Pregnancy

BioTechniques News New research shows that immune cells are the initial target for Zika virus infection, resulting in immunosuppression. What new insight […]

September 7, 2017News

Surveying the Mitochondrial Machinery

BioTechniques News A new comprehensive classification map of mitochondrial proteins promises new insights into mitochondrial function. Full BioTechniques Article here Powered by […]

September 6, 2017News

Taking Charge of Extracellular Vesicles

BioTechniques News Researchers have developed a novel approach to isolate highly purified extracellular vesicles. Full BioTechniques Article here Powered by WPeMatico

September 6, 2017News

Ribosomal DNA and Cancer

BioTechniques News What can changes in ribosomal DNA, an often-overlooked part of the genome, tell us about cancer? Full BioTechniques Article here […]

September 6, 2017News

Researchers Unravel the Magical Mystery of Psychedelic Mushrooms

BioTechniques News After more than half a century of mystery, researchers reveal how mind-altering “magic mushrooms” naturally create psilocybin, the psychoactive compound […]

September 5, 2017News

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

BIOtech Now George Goodno Researchers and biotech leaders continue to discover new cures and treatments that are making a positive difference in […]

August 29, 2017News

Vaccines Play Key Role in Curbing Antimicrobial Resistance

BIOtech Now Daniel Seaton Antimicrobial resistance (AMR) is one of the greatest public health threats facing the global community – by 2050, […]

August 25, 2017News

If It Isn’t Broke …

BIOtech Now Brian Newell Congress created the Medicare Part D prescription drug program in 2003, and for more than a decade, the […]

August 24, 2017News

The Benefits of Immunization

BIOtech Now BIOtechNOW Editor In today’s Philadelphia Inquirer, BIO President & CEO Jim Greenwood authored an op-ed for National Immunization Month dismantling […]

August 22, 2017News

Three Encouraging Steps on Prescription Drug Costs

BIOtech Now Brian Newell It’s a refrain you hear often in the news: Drug costs are soaring and nothing is being done […]

Posts navigation

< 1 … 40 41 42 … 48 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • New ‘asthma-on-a-chip’ technology opens the door to future treatments
  • Breast milk nutrient shapes immune development in mice
  • A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
  • The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
  • New gene therapy reverses Fragile X deficits in preclinical model
  • May I have your attention, please: ancient neurons hold ADHD clues
© 2026 V-Biognostics. Proudly powered by Sydney